Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-06 · accession 0002022345-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-10 | 2025-11-06 | BIO | BARRY JAMES | EVP, Pres, LSG | S - Sale | $306.18 | -699.87 | 509.68 | -58% | -$214.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2025-11-06 | S | D | 699.87 | $306.18 | 509.68 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.104 to $306.230, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |